NCT03294122 Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck Cancer Status UNKNOWN Phase N/A
NCT03289962 A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors Status COMPLETED Phase PHASE1
NCT03282461 A Microdose Evaluation Study of ABY-029 in Head and Neck Oncology Surgery Status COMPLETED Phase EARLY_PHASE1
NCT03268993 Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer Status COMPLETED Phase NA
NCT03266276 Assessing Impact of CCO's PSO & PC Pathway in Ambulatory HNC Clinics Status COMPLETED Phase NA
NCT03265873 Contribution of the ENT (Ear, Nose, and Throat) Surgeon's Clinical Evaluation to the Contouring of Target Volumes and Organs Eligible for Radiotherapy in Head and Neck Cancers Status COMPLETED Phase N/A
NCT03252821 Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing Radiotherapy Status COMPLETED Phase NA
NCT03247712 Neoadjuvant Immunoradiotherapy in Head & Neck Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03246854 A Study of DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer Status TERMINATED Phase PHASE1
NCT03245788 Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study Status COMPLETED Phase NA
NCT03238638 A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy Status WITHDRAWN Phase PHASE2
NCT03212404 Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03207867 A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma Status TERMINATED Phase PHASE2
NCT03182959 Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer Status COMPLETED Phase EARLY_PHASE1
NCT03170960 Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1